Dexmedetomidine 0.004 MG/ML
DrugIncidence of polyuria during the intraoperative period, associated with dexmedetomidine .
NCT Number: NCT06535386
Dexmedetomidine is an a2-adrenergic receptor agonist drug, widely used in intensive care for the sedation of patients on mechanical ventilation, as well as in the operating room during invasive procedures and during general anesthesia. It also has anti-inflammatory properties and reduces the need for opioids and benzodiazepines, which leads to a lower incidence of delirium associated with these drugs.
Among the frequent adverse effects associated with the administration of dexmedetomidine we can find bradycardia and hypotension, while some studies carried out in animals have shown that it can increase the diuretic rate.
Polyuria related to pharmacological agonism of a2-adrenergic receptors has been described in vitro and in studies performed in animal models, and is believed to be the result of functional antagonism of arginine vasopressin. Despite its widespread use as a sedative and adjunctive anesthetic, there are very few reports in the literature of dexmedetomidine-related polyuria in humans.
Currently there are no reports in the literature on the incidence of polyuria induced by the intraoperative administration of dexmedetomidine.
Trial opening soon.
Get Notified18 year–90 year
All sexes
Observational
This is a prospective, observational study designed to determine the incidence of polyuria, defined as urine output greater than 150 ml/h or 3 ml/kg/h, associated with the administration of dexmedetomidine during the intraoperative period.
The investigators will prospectively and consecutively study all patients scheduled for high complexity surgery under general anesthesia for a period of 4 months.
The diuretic rate will be quantified in ml/hour. A urine sample will be taken two hours after the start of surgery to assess sodium and urinary density, and an arterial blood sample will be taken to determine serum sodium.
Hydration will be recorded in milliliters per hour, detailing the type of solution used.
All data obtained will be captured in a RedCap data collection form.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Incidence of polyuria during the intraoperative period, associated with dexmedetomidine .
Time frame: 3 hours
Determine the incidence of polyuria defined as urine output greater than 150 ml/h or 3 ml/kg/h associated with the administration of dexmedetomidine during the intraoperative period in patients scheduled for highly complex surgery
Time frame: 3 hours
Determine if there is any correlation between the appearance of polyuria associated with the administration of dexmedetomidine and age, sex, type of surgery, other anesthetic drugs, and esophageal temperature.
Contact information is provided by the study sponsor or research team.
Cecilia M Acosta, MD
CONTACT
Esteban Gandara, MD
CONTACT
Hospital Privado de Comunidad de Mar del Plata
Other
Incidence of Polyuria Associated With Dexmedetomidine During the Intra-operative Period
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04526340
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT03858439
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney
Hamilton, Ontario, Canada
View Trial DetailsNCT01036841
Behavior, Behavioral Symptoms
Ghent, Belgium
View Trial DetailsNCT02195713
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Augusta, Georgia, United States
View Trial Details